GlassScriptPhysician profile
Lindsay M Gates
NPI 1285952085
$3,980.49
in general payments reported to CMS, 2019-2025
24 companies · $1,264 in 2025
The $1,264 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $418 · 2020: $67.52 · 2021: $26.36 · 2022: $976 · 2023: $1,002 · 2024: $226 · 2025: $1,264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,077 · Education: $415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,077.36 |
| Education | $415.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,391.98 | 2019-2025 | Gore Excluder Aaa Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Iliac Branch Endoprosthesis |
| Penumbra, INC. | $556.34 | 2023-2025 | Indigo System, Ruby Coil, Penumbra System |
| Medtronic, INC. | $439.45 | 2022-2025 | Venaseal, Endurant Iis, Closurefast |
| Cvrx, INC. | $316.80 | 2024-2025 | Barostim Neo System |
| Boston Scientific Corporation | $296.65 | 2022-2025 | Varithena Administration Pack, Eluvia, Angiojet Ultra 5000a |
| Teleflex LLC | $183.49 | 2025 | Manta |
| Shockwave Medical, INC | $160.60 | 2025 | |
| Solventum Corporation | $119.00 | 2025 | V.A.C. Veraflo Cleanse Choice, Activ.A.C., Promogran Prisma |
| Novartis Pharmaceuticals Corporation | $104.98 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $49.76 | 2022-2024 | Verquvo |
| Smith+Nephew, INC. | $47.69 | 2024-2025 | Grafix Pl, Pico 14, Renasys Touch |
| Janssen Pharmaceuticals, INC | $39.95 | 2022 | |
| Medtronic Vascular, INC. | $36.28 | 2019 | |
| Kerecis Limited | $31.93 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Karl Storz Endoscopy-America | $31.91 | 2023 | Radiance |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $27.75 | 2025 | Clottriever Bold Catheter |
| Bard Peripheral Vascular, INC. | $24.81 | 2025 | Rotarexs 6 F X 135 Cm |
| Organogenesis INC. | $24.35 | 2025 | Puraply Wound Matrix |
| Integra Lifesciences Corporation | $20.85 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Astrazeneca Pharmaceuticals LP | $17.10 | 2023 | Andexxa |
| Actelion Pharmaceuticals US, INC. | $16.50 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.00 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $13.78 | 2023 | Camzyos |
| Lexicon Pharmaceuticals, INC. | $13.54 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsay Gates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.